06/02/2025 7:06 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2025 3:03 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2025 10:59 AM | Ascendis Pharma A/S (Subject) JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
05/14/2025 9:47 AM | Ascendis Pharma A/S (Subject) T. Rowe Price Investment Management, Inc. (Filed by)
| Form SCHEDULE 13G | |
05/12/2025 11:13 AM | Ascendis Pharma A/S (Subject) Shu Aimee (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2025 6:18 AM | Ascendis Pharma A/S (Subject) Shu Aimee (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/05/2025 3:14 PM | Ascendis Pharma A/S (Subject) JENSEN MICHAEL WOLFF (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/01/2025 3:15 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/09/2025 3:01 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/31/2025 3:01 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2025 3:17 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for ASND and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Ascendis Pharma A/S and its competitors with MarketBeat's FREE daily newsletter.
|
03/12/2025 3:48 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2025 4:03 PM | Ascendis Pharma A/S (Subject) JENSEN MICHAEL WOLFF (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2025 3:51 PM | Ascendis Pharma A/S (Subject) MIKKELSEN JAN MOLLER (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2025 1:31 PM | Ascendis Pharma A/S (Subject) Bodenhoff Mads (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025 7:38 PM | Ascendis Pharma A/S (Subject) Hartvig Camilla Harder (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025 7:27 PM | Ascendis Pharma A/S (Subject) Fairey William (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025 7:32 PM | Ascendis Pharma A/S (Subject) Bodenhoff Mads (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025 7:15 PM | Ascendis Pharma A/S (Subject) Morrison Lisa (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025 7:22 PM | Ascendis Pharma A/S (Subject) IMANI SIHAM (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025 6:50 PM | Ascendis Pharma A/S (Subject) PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025 6:55 PM | Ascendis Pharma A/S (Subject) JENSEN MICHAEL WOLFF (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025 7:00 PM | Ascendis Pharma A/S (Subject) SMITH SCOTT THOMAS (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025 7:04 PM | Ascendis Pharma A/S (Subject) SINGEL STINA (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025 7:09 PM | Ascendis Pharma A/S (Subject) Cha Albert (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025 7:12 PM | Ascendis Pharma A/S (Subject) HOLTUG LARS (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025 6:40 PM | Ascendis Pharma A/S (Subject) JENSEN FLEMMING STEEN (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025 6:45 PM | Ascendis Pharma A/S (Subject) SPROGOE KENNETT (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025 3:02 PM | Ascendis Pharma A/S (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/21/2025 5:11 AM | Ascendis Pharma A/S (Subject) SINGEL STINA (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025 4:06 PM | Ascendis Pharma A/S (Subject) PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025 3:56 PM | Ascendis Pharma A/S (Subject) JENSEN MICHAEL WOLFF (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025 10:54 AM | Ascendis Pharma A/S (Subject) JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
02/12/2025 3:15 PM | Ascendis Pharma A/S (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
02/12/2025 2:24 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/11/2025 8:15 AM | Ascendis Pharma A/S (Subject) WESTFIELD CAPITAL MANAGEMENT CO LP (Filed by)
| Form SCHEDULE 13G/A | |
01/15/2025 3:39 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/13/2025 5:03 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/13/2025 5:05 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/30/2024 3:04 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/17/2024 5:04 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
"I'm risking my reputation on this" (Ad) Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented.
And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots…
What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book. Claim your FREE copy of Crypto Revolution now. |
12/10/2024 4:02 PM | Ascendis Pharma A/S (Subject) PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024 4:07 PM | Ascendis Pharma A/S (Subject) JENSEN MICHAEL WOLFF (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024 4:16 PM | Ascendis Pharma A/S (Subject) SINGEL STINA (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024 3:44 PM | Ascendis Pharma A/S (Subject) MIKKELSEN JAN MOLLER (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/03/2024 3:35 PM | Ascendis Pharma A/S (Subject) JENSEN FLEMMING STEEN (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024 4:46 PM | Ascendis Pharma A/S (Subject) RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024 1:57 PM | Ascendis Pharma A/S (Subject) JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
11/14/2024 8:31 AM | Ascendis Pharma A/S (Subject) Avoro Capital Advisors LLC (Filed by)
| Form SC 13G/A | |
11/13/2024 3:02 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/12/2024 8:51 AM | Artisan Partners Limited Partnership (Filed by) Ascendis Pharma A/S (Subject)
| Form SC 13G/A | |
11/08/2024 9:34 AM | Ascendis Pharma A/S (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/04/2024 6:05 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/30/2024 7:35 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/27/2024 3:59 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/18/2024 4:20 PM | Ascendis Pharma A/S (Filer)
| Form 424B5 | |
09/18/2024 3:01 PM | Ascendis Pharma A/S (Filer)
| Form F-3ASR | |
09/16/2024 6:28 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024 6:32 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/11/2024 3:01 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024 4:10 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024 4:11 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024 4:14 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/12/2024 6:05 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |